Anna Karmann Email

Chief Medical Officer . AdvanCell

Current Roles

Employees:
61
Revenue:
$9.5M
About
AdvanCell is a radiopharmaceutical company developing an innovative pipeline of 212Pb-based Targeted Alpha Therapies for cancer patients. AdvanCell’s platform technology addresses the most significant challenge in Targeted Alpha Therapy – the reliable and scalable supply of isotope. AdvanCell’s novel drug discovery, preclinical processes, and state-of-the-art facilities leverage daily access to 212Pb, the ideal isotope for Targeted Alpha Therapy. For more information, please visit www.advancell.com.au
AdvanCell Address

Sydney, null
AUS
AdvanCell Email

Past Companies

RayzeBioVice President, Global Product Leader
Stanford Byers Center for BiodesignBiodesign Advisory Council Member, Digital Health
McKinsey & CompanyEngagement Manager